FLOT1 and multiple sclerosis: We screened the presence of anti-FLOT-1/2 antibodies in 282 patients fulfilling diagnostic criteria for multiple sclerosis (252 sera and 50 CSF), and 260 controls (including healthy donors and patients with other neurological disorders).